Á¦1Â÷ ±¹Á¦ÀÏÂ÷ÀÇ·áÇмú´ëȸ ¡¤ 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-04-19
±³À°ÀÏÀÚ : 2024-04-19
±³À°Àå¼Ò : ´õÄÉÀÌÈ£ÅÚ ÄÁº¥¼Ç¼¾Å¸
±³À°ÁÖÁ¦ : Á¦1Â÷ ±¹Á¦ÀÏÂ÷ÀÇ·áÇмú´ëȸ ¡¤ 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ Ãá°èÇмú´ëȸ 1ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇÑ°¡Á¤ÀÇÇÐȸ
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 02-2135-9319
À̸ÞÀÏ : kafmconference@peoplenvalue.com
±³À°Á¾·ù : ±âŸ
Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 180,000¿ø
ºñ°í Á¤È¸¿ø(Àü¹®ÀÇ), ±¹Á¦È¸¿ø, Çùµ¿È¸¿ø, ¸í¿¹È¸¿ø 180,000¿ø, Á¤È¸¿ø(75¼¼ ÀÌ»ó) ¹«·á, Á¤È¸¿ø(65¼¼ ÀÌ»ó 75¼¼ ¹Ì¸¸) 130,000¿ø, Á¤È¸¿ø(65¼¼ ÀÌ»ó Çмú¿øȸ¿ø) 110,000¿ø, Á¤È¸¿ø(65¼¼ ¹Ì¸¸ Çмú¿øȸ¿ø) 150,000¿ø, Á¤È¸¿ø(ÀüÀÓÀÇ) 150,000¿ø, Á¤È¸¿ø(±ºÀÇ°ü¤ý°øº¸ÀÇ) 130,000¿ø, Á¤È¸¿ø(°³¿øÀÇ ÀÏ¿ä 1ÀÏ) 40,000¿ø, ÁØȸ¿ø(Àü°øÀÇ) ¹«·á, ºñȸ¿ø(ÀÇ»ç) 200,000¿ø, ºñȸ¿ø(°³¿øÀÇ ÀÏ¿ä 1ÀÏ) 70,000¿ø, ºñȸ¿ø(ÀÇ»ç ¿Ü ÀÇ·áÁ¾»çÀÚ) 130,000¿ø, ºñȸ¿ø(Çлý) ¹«·á, ºñȸ¿ø(ÈÄ¿ø»ç) ¹«·á, ºñȸ¿ø(µ¿¹Ý°¡Á·) ¹«·á, ºñȸ¿ø(ÇØ¿Ü) ¹«·á / *´çÀϵî·Ïºñ 3¸¸¿ø Ãß°¡µÊ
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë A 14:00~14:30 À¯»ê±Õ°ú üÁö¹æ·®ÀÇ ¿¬°ü¼º (±¹³»¿Ü ¸®ºä ¹× ¼øõÇâ ´ëÇк´¿ø ³»ºÎ¿¬±¸ÀÚ·á ±â¹Ý) ±è¹ÎÁö(¼øõÇâ´ëÇб³ ¼¿ïº´¿ø)
ÈÞ½Ä 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë A 14:30~15:00 ÈÞ½Ä ()
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë A 15:00~15:15 ȯÀÚÁ᫐ ÀÏÂ÷ÀÇ·á 4ÇüÀÇ¿ø ¿î¿µ °æÇè ¹ÚÇý¹Î(Àϻ꺴¿ø)
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë A 15:15~15:30 ȯÀÚÁ᫐ ÀÏÂ÷ÀÇ·á ½Ã¹ü»ç¾÷ ¿î¿µ/³×Æ®¿öÅ© ¸ðÇü ¹Ú¼º¹è(Àϻ꺴¿ø)
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë A 15:30~15:45 ȯÀÚÁ᫐ ÀÏÂ÷ÀÇ·á ½Ã¹ü»ç¾÷ ±³À°¸ðÇü Á¶ºñ·æ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë A 15:45~16:00 ȯÀÚÁ᫐ ÀÏÂ÷ÀÇ·á ½Ã¹ü»ç¾÷ ÁöºÒ¸ðÇü ¿ÀÁÖȯ(¼¿ïÀÇ´ë)
Åä·Ð 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë A 16:00~16:10 ÁöÁ¤Åä·Ð ÀÌ»óÀÏ(¿ï»êÀÇ´ë)
Åä·Ð 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë A 16:10~16:20 ÁöÁ¤Åä·Ð ÀÓÁ¾ÇÑ(ÀÎÇÏÀÇ´ë)
Åä·Ð 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë A 16:20~16:25 ÁöÁ¤Åä·Ð ¹ÚÁö¿µ(±¹¹Î°Ç°º¸Çè°ø´Ü)
Åä·Ð 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë A 16:25~16:30 ÁöÁ¤Åä·Ð °ÁØ(º¹ÁöºÎ)
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë B 13:45~14:00 ¿ø°ÝÀÇ·á ÇöȲ ¿À½Â¹Î(¼¿ïƯº°½Ã ¼¿ïÀÇ·á¿ø)
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë B 14:00~14:15 ¿ø°ÝÀÇ·á¿¡ ´ëÇÑ ÀÇ·áÀι®ÇÐÀû ¼ºÂû ¹ÚÁßö(ÀÎõ¼º¸ðº´¿ø)
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë B 14:15~14:30 ICTÈ°¿ë ÀÀ±ÞȯÀÚ °ü¸® ½Ã½ºÅÛ ±èÁöÈÆ(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë B 14:30~14:45 ÀÇ·áAI½Ã½ºÅÛÀÇ Áø·áÇöÀå Àû¿ë ÃÖÇö¼®(µö³ëÀ̵å)
ÈÞ½Ä 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë B 14:45~15:00 ÈÞ½Ä ()
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë B 15:00~15:30 ÁÖ¼Ò·Ï ¾÷µ¥ÀÌÆ®¸¦ ÅëÇÑ È¿°úÀû ȸ¿ø°ü¸® À¯È¿¼±(ÃæºÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë B 15:30~16:00 ¿ì¸®ÀÇ Á¤Ã¼¼ºÀ» ¹Ý¿µÇÏ´Â Àü¹®°ú¸ñ¸í º¯°æ ÀÌÀç¿ì(ÃæºÏ´ëÇб³)
±³À°½Ã°£ 04¿ù 19ÀÏ Å©¸®½ºÅ»º¼·ë B 16:00~16:30 ÀÇ·áȯ°æ º¯È¿¡ µû¸¥ °¡Á¤ÀÇÇÐÀÇ ¹Ì·¡ È«½Â±Ç(·ÏÇâÀÇ·áÀç´Ü)
±³À°½Ã°£ 04¿ù 19ÀÏ ÇѰȦ 13:30~14:30 Nutritional Challenges in Metabolic Syndrom ÀÌÀ±¾Æ(¼ººó¼¾Æ®º´¿ø °¡Á¤ÀÇÇаú)
ÈÞ½Ä 04¿ù 19ÀÏ ÇѰȦ 14:30~15:00 ÈÞ½Ä ()
±³À°½Ã°£ 04¿ù 19ÀÏ ÇѰȦ 15:00~15:30 Non-pharmacological Management and Pharmacotherapy of Chronic Kidney Disease (CKD) in Primary Care ¼ÕÁ¤½Ä(ÇѾç´ëº´¿ø)
±³À°½Ã°£ 04¿ù 19ÀÏ ÇѰȦ 15:30~16:00 Approach and Management of Eye Conditions Associated with Chronic Kidney Disease (CKD) ÀÌÀåÈÆ(¿À»ê¹àÀº¾È°ú)
±³À°½Ã°£ 04¿ù 19ÀÏ ÇѰȦ 16:00~16:30 Trends in the Incidence of Sexually Transmitted Infections (STIs) and Updates on Clinical Guidelines in South Korea ¹è»ó¶ô(ÀÇÁ¤ºÎ ¼º¸ðº´¿ø ºñ´¢ÀÇÇаú)
±³À°½Ã°£ 04¿ù 19ÀÏ ±Ý°È¦ 13:00~13:45 ÃֽŠºòµ¥ÀÌÅÍ È°¿ë ¿¬±¸¸¦ À§ÇÑ Ä£Àý °¡À̵å: ±¹¹Î°Ç°º¸Çè°ø´Ü ¹× ±¹¹Î°Ç°¿µ¾çÁ¶»ç µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ Æ÷°ýÀû Á¢±Ù ÇÑ°æµµ(¼þ½Ç´ëÇб³)
±³À°½Ã°£ 04¿ù 19ÀÏ ±Ý°È¦ 13:45~14:30 KoGES(Çѱ¹À¯Àüü¿ªÇבּ¸, KoGES) µ¥ÀÌÅ͸¦ È°¿ëÇÑ ¿¬±¸°³·Ð: ±ËÀûºÐ¼®±â¹ýÀ» Áß½ÉÀ¸·Î ÀÌÁØÇõ(À»Áö´ëÇб³ ÀÇ°ú´ëÇÐ)
ÈÞ½Ä 04¿ù 19ÀÏ ±Ý°È¦ 14:30~15:00 ÈÞ½Ä ()
±³À°½Ã°£ 04¿ù 19ÀÏ ±Ý°È¦ 15:00~16:30 ¸ÞŸºÐ¼®°ú ±Ù°ÅÁßÁü Áø·á ¸í½Â±Ç(±¹¸³¾Ï¼¾ÅÍ)